Latest Breaking News On - Apellis pharmaceuticals inc - Page 21 : comparemela.com

Apellis: EU s CHMP Adopts Negative Opinion For Pegcetacoplan For GA; To Seek Re-Examination Of MAA

Apellis Pharmaceuticals, Inc. (APLS) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a negative opinion for Pegcetacoplan for geographic atrophy or GA.

Jeffrey eiseleMore such health newsApellis pharmaceuticals incApellis pharmaceuticalsEuropean medicines agencyMedicinal productsHuman useNegative opinionGeographic atrophyPellis negative opinion

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMeredith kayaLissa pavlukJeffrey eiseleEuropean medicines agencyResearch groupExchange commissionExchange commission onApellis pharmaceuticals incCommittee for medicinal products human useLancet glob healthMedicinal productsHuman useGeographic atrophyApellis pharmaceuticalsForward looking statement statements

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) General Counsel Sells $271,960 00 in Stock

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) General Counsel Sells $271,960 00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesDavido watsonRobertw bairdApellis pharmaceuticalsQuarter for apellis pharmaceuticalsWells fargo companyApellis pharmaceuticals incJennison associatesApellis pharmaceuticals price performanceAmerican investors coLisanti capital growthApellis pharmaceuticals company profileNeedham companyNews ratings for apellis pharmaceuticals dailyInstitutional investors weigh in on apellis pharmaceuticalsEnvestnet asset management inc

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) General Counsel David O Watson Sells 4,184 Shares

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) General Counsel David O Watson Sells 4,184 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Davido watsonRobertw bairdApellis pharmaceuticals incAdvisor group holdings incNeedham companyApellis pharmaceuticalsApellis pharmaceuticals stock downNeuberger berman groupFirst horizon advisors incApellis pharmaceuticals company profileNews ratings for apellis pharmaceuticals dailyQuarter for apellis pharmaceuticalsCim investment management incGet free reportGeneral counsel davidPharmaceuticals stock down

Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 2 9%

Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 2 9%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesCedric francoisJeffrey eiseleApellis pharmaceuticals company profilePricet rowe associates incMorgan stanleyApellis pharmaceuticalsNorges bankHedge funds weigh in on apellis pharmaceuticalsApellis pharmaceuticals price performanceSecurities exchange commissionJennison associatesGoldman sachs groupNews ratings for apellis pharmaceuticals dailyNeedham companyApellis pharmaceuticals inc